newsLynparza approved by FDA to treat germline BRCA-mutated metastatic pancreatic cancer2 January 2020 | By Hannah Balfour (European Pharmaceutical Review)The FDA has approved Lynparza as a first-line treatment after it reduced the risk of disease progression or death by 47 percent in patients.
